AFMD: Affimed N.V. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 11.47
Enterprise Value ($M) 11.47
Book Value ($M) 0.00
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.99
Return on Equity (ROE) -1.72

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets 0.00
Assets 0.00
Liabilities 0.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A 683 Capital Management, LLC 4.30 -29.20

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-08 24,229 92,655 26.15
2025-05-07 28,403 197,285 14.40
2025-05-06 17,173 92,308 18.60
2025-05-05 23,222 123,378 18.82

(click for more detail)

Similar Companies
ACIU – AC Immune SA ACRV – Acrivon Therapeutics, Inc.
ADMA – ADMA Biologics, Inc. ALT – Altimmune, Inc.
ANIP – ANI Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Affimed N.V.